Encouraging article in the NYT regard... - Advanced Prostate...

Advanced Prostate Cancer

21,584 members27,020 posts

Encouraging article in the NYT regarding a possible way to make immunotherapy work well for prostate cancer given PD-L1 discoveries...

JLS1 profile image
JLS1
2 Replies

VERY interesting article in the NYT last Thursday:

"By Matt Richtel

April 4, 2019

Cancer immunotherapy drugs, which spur the body’s own immune system to attack tumors, hold great promise but still fail many patients. New research may help explain why some cancers elude the new class of therapies, and offer some clues to a solution.

The study, published on Thursday in the journal Cell, focuses on colorectal and prostate cancer. These are among the cancers that seem largely impervious to a key mechanism of immunotherapy drugs."........

nytimes.com/2019/04/04/heal...

Written by
JLS1 profile image
JLS1
To view profiles and participate in discussions please or .
Read more about...
2 Replies
tallguy2 profile image
tallguy2

Thanks for posting this article. The conclusion: “Interfering with the PD-L1 traveling to lymph nodes “can lead to a long-lasting, systemic, anti-tumor immunity,” the paper concluded.” Is extremely promising.

NPfisherman profile image
NPfisherman

I agree with tallguy2...this is promising...they don't say how they blocked/interfered with the PD-L1...Would be interested in that information...Science is amazing...

Fish

Not what you're looking for?

You may also like...

First Scans after Chemo - Good News!

his first scans post chemo Thursday, March 18. The scans show his cancerous lymph nodes have all...

How does one distinguish between supplements that reduce PSA as opposed to masking PSA?

levels are caused by lower cancerous activity....

Does Jevtana/carboplatin cross the blood-brain barrier?

the immunotherapy drugs supercharged our prostate cancer! Before I could start my next trial drug,...

New prostate cancer treatment concept

castration-resistant prostate cancer....

Opdivo-Yervoy Combo Shows Signs of Activity in CRPC Patients with Metastases

for MCRPC. The combo of immunotherapy drugs are what some think will be the key bigger results....